Kwality Pharma

{
  "main_header": {
    "sid": 1002639,
    "name": "Kwality Pharma",
    "stock_name": "Kwality Pharma",
    "full_name": "Kwality Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/kwality-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,082.00",
    "chg": 4.4,
    "chgp": "0.41%",
    "dir": 1,
    "prev_price": "1,077.60",
    "mcapval": "1,122.70 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539997,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE552U01010",
    "curr_date": "Jan 30",
    "curr_time": "",
    "bse_nse_vol": "1.74 k",
    "exc_status": "Active",
    "traded_date": "Jan 30, 2026",
    "traded_date_str": "2026 01 30",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kwality-pharma-1002639-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kwality Pharmaceuticals Upgraded to Buy on Strong Financial and Technical Momentum",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-upgraded-to-buy-on-strong-financial-and-technical-momentum-3810745",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KwalityPharmace_mojoScore_3810745.png",
        "date": "2026-01-30 08:12:35",
        "description": "Kwality Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. The upgrade, effective from 29 Jan 2026, follows a robust quarter and sustained long-term growth, positioning the company favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-3810649",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KwalityPharmace_technicaldot_3810649.png",
        "date": "2026-01-30 08:02:22",
        "description": "Kwality Pharmaceuticals Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from a mildly bullish to a more robust bullish trend. This development comes alongside an upgrade in the company’s Mojo Grade from Hold to Buy, reflecting improved market sentiment and technical strength in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kwality Pharmaceuticals Gains 1.59%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-gains-159-3-key-factors-driving-the-weeks-momentum-3803325",
        "imagepath": "",
        "date": "2026-01-24 13:05:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>19 Jan:</strong> Stock opens at Rs.1,073.75, down 1.72% amid broader market weakness</p>\n                    <p><strong>21 Jan:</strong> Downgrade to Hold rating announced; technical momentum shifts to mildly bullish</p>\n                    <p><strong>22 Jan:</strong> Bullish momentum shift observed; stock surges 4.43% to Rs.1,129.20</p>\n                    <p><strong>23 Jan:</strong> Stock closes at Rs.1,109.85, down 1.71% on profit-taking</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,073.75</div>\n  ..."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-bullish-momentum-shift-amid-mixed-technical-signals-3799528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KwalityPharmace_technicaldot_3799528.png",
        "date": "2026-01-22 08:01:39",
        "description": "Kwality Pharmaceuticals Ltd has experienced a notable shift in price momentum, supported by a series of bullish technical indicators that suggest a strengthening trend in the Pharmaceuticals & Biotechnology sector. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s technical parameters reveal an encouraging outlook for investors seeking growth opportunities."
      },
      {
        "title": "Kwality Pharmaceuticals Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-3797836",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KwalityPharmace_mojoScore_3797836.png",
        "date": "2026-01-21 08:17:35",
        "description": "Kwality Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 20 Jan 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and strong returns over recent years, evolving technical signals and valuation considerations have prompted a more cautious stance."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-3797714",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KwalityPharmace_technicaldot_3797714.png",
        "date": "2026-01-21 08:04:07",
        "description": "Kwality Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a slight dip in the share price, the stock’s technical indicators present a nuanced picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical developments, key indicator readings, and the stock’s performance relative to broader market benchmarks."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kwality-pharmaceuticals-ltd-is-rated-buy-3795809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KwalityPharmace_mojoScore_3795809.png",
        "date": "2026-01-20 10:10:59",
        "description": "Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 14 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 20 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3791382",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KwalityPharmace_technicaldot_3791382.png",
        "date": "2026-01-14 08:03:20",
        "description": "Kwality Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early January 2026. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to exhibit a complex interplay of technical indicators that suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kwality Pharmaceuticals Ltd Sees Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kwality-pharmaceuticals-ltd-sees-bullish-momentum-amid-technical-upgrades-3789322",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KwalityPharmace_technicaldot_3789322.png",
        "date": "2026-01-12 08:03:43",
        "description": "Kwality Pharmaceuticals Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from a mildly bullish to a bullish trend. Despite some mixed signals from momentum oscillators, the stock’s recent performance and technical parameters suggest growing investor confidence amid a volatile market backdrop."
      }
    ],
    "total": 235,
    "sid": "1002639",
    "stock_news_url": "https://www.marketsmojo.com/news/kwality-pharmaceuticals-1002639"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "28-Jan-2026",
      "details": "Appointment of Mr. Bhavesh Mahajan as Additional Independent Director on the Board of the Company",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Appointment Of Mr. Bhavesh Mahajan (DIN: 09614108) As Additional Independent Director Of The Company",
      "datetime": "28-Jan-2026",
      "details": "We wish to inform you that on the recommendation of Nomination and Remuneration Committee the Board of Directors of the Company at its meeting held today i.e. on January 28 2026 has inter alia considered and approved the appointment of Mr. Bhavesh Mahajan (DIN: 09614108) as Additional Independent Director of the Company who shall hold office for a period of five (5) consecutive years with effect from 28th January 2026 to 27th January 2031(both days inclusive) subject to approval of the shareholders of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Jan-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter Ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 05 Jan 17",
          "dt": "2017-01-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Kwality Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Oct 17",
          "dt": "2017-10-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kwality Pharmaceuticals Upgraded to Buy on Strong Financial and Technical Momentum

2026-01-30 08:12:35

Kwality Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. The upgrade, effective from 29 Jan 2026, follows a robust quarter and sustained long-term growth, positioning the company favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Kwality Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Technical Upgrades

2026-01-30 08:02:22

Kwality Pharmaceuticals Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from a mildly bullish to a more robust bullish trend. This development comes alongside an upgrade in the company’s Mojo Grade from Hold to Buy, reflecting improved market sentiment and technical strength in the Pharmaceuticals & Biotechnology sector.

Read full news article

Kwality Pharmaceuticals Gains 1.59%: 3 Key Factors Driving the Week’s Momentum

2026-01-24 13:05:27

Key Events This Week

19 Jan: Stock opens at Rs.1,073.75, down 1.72% amid broader market weakness

21 Jan: Downgrade to Hold rating announced; technical momentum shifts to mildly bullish

22 Jan: Bullish momentum shift observed; stock surges 4.43% to Rs.1,129.20

23 Jan: Stock closes at Rs.1,109.85, down 1.71% on profit-taking

Week Open

Rs.1,073.75

...

Read full news article

Kwality Pharmaceuticals Ltd Sees Bullish Momentum Shift Amid Mixed Technical Signals

2026-01-22 08:01:39

Kwality Pharmaceuticals Ltd has experienced a notable shift in price momentum, supported by a series of bullish technical indicators that suggest a strengthening trend in the Pharmaceuticals & Biotechnology sector. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s technical parameters reveal an encouraging outlook for investors seeking growth opportunities.

Read full news article

Kwality Pharmaceuticals Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-01-21 08:17:35

Kwality Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 20 Jan 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and strong returns over recent years, evolving technical signals and valuation considerations have prompted a more cautious stance.

Read full news article

Kwality Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-21 08:04:07

Kwality Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a slight dip in the share price, the stock’s technical indicators present a nuanced picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical developments, key indicator readings, and the stock’s performance relative to broader market benchmarks.

Read full news article

Kwality Pharmaceuticals Ltd is Rated Buy

2026-01-20 10:10:59

Kwality Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 14 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 20 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Kwality Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-01-14 08:03:20

Kwality Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early January 2026. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to exhibit a complex interplay of technical indicators that suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Kwality Pharmaceuticals Ltd Sees Bullish Momentum Amid Technical Upgrades

2026-01-12 08:03:43

Kwality Pharmaceuticals Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from a mildly bullish to a bullish trend. Despite some mixed signals from momentum oscillators, the stock’s recent performance and technical parameters suggest growing investor confidence amid a volatile market backdrop.

Read full news article

View All News